Food Allergen Testing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The food allergen testing market size is projected to grow from USD 1.18 billion in 2025 to USD 1.35 billion in 2026, reaching USD 1.89 billion by 2031, with a CAGR of 6.96% during 2026-2031. This report Segments the Industry Into Technology (Immunoassay-Based, PCR-Based, Mass-Spectrometry-Based, Spectroscopy and Imaging, Others), Application (Bakery and Confectionery, Dairy Products, Seafood and Meat Products, Beverages, Baby Food and Infant Formula, Others), and Geography (North America, Europe, and More). The Market Forecasts are Provided in Terms of Value (USD).

Global Food Allergen Testing Market Trends and Insights

Surge in food recalls and brand-risk costs

The increasing frequency and economic impact of allergen-related food recalls are driving significant changes in the food industry's approach to risk management. Undeclared allergens remain the primary cause of global recalls. In the United Kingdom, 53 cases of undeclared allergen recalls were reported in 2024, representing a 10% increase and highlighting ongoing challenges in preventing cross-contamination. Regulatory changes are also shaping industry practices. The FDA’s Food Safety Modernization Act (FSMA) Section 204, scheduled for enforcement in January 2026, requires digital traceability systems to improve visibility into allergen control failures and their associated legal and financial risks. This regulation is encouraging manufacturers to focus on proactive testing and preventive measures rather than reactive responses to recalls, leading to a steady increase in the adoption of rapid allergen detection technologies. Risk reduction and regulatory compliance are particularly crucial in the foodservice sector, which reports the second-highest rate of allergic incidents after household consumption.

Tightening allergen labeling laws and enforcement

The push for regulatory alignment across major global markets is increasing pressure on food manufacturers, extending beyond traditional labeling requirements to encompass production practices and supply chain verification protocols. In 2024, the FDA released Edition 5 guidance on allergen control, introducing more stringent requirements for cleaning validation and environmental monitoring. Concurrently, the USDA’s Food Safety and Inspection Service launched a dedicated allergen verification initiative targeting meat and poultry processors. Similarly, the Dutch Food and Consumer Product Safety Authority revised its guidelines on preventing cross-contact, detailing testing frequencies and analytical methods for manufacturers. These regulatory updates significantly affect multinational food companies, which must manage varying levels of enforcement across regions, with Europe imposing some of the most stringent compliance standards. Emerging markets are also impacted, as export-driven producers adopt international allergen testing protocols to access high-value markets.

High cost of testing technologies

The substantial capital requirements for advanced allergen testing platforms pose significant entry barriers, particularly for small and medium-sized food manufacturers, which represent the majority of global food production capacity. Confirmatory allergen analysis using LC-MS/MS systems demands an initial investment exceeding USD 500,000, with annual maintenance and consumable costs amounting to approximately USD 100,000 per instrument. Beyond equipment expenses, additional costs include specialized personnel training, method validation, and regulatory compliance documentation, collectively surpassing USD 1 million for comprehensive allergen testing capabilities. This cost structure has led to a segmented market, where large multinational corporations operate in-house testing facilities. At the same time, smaller manufacturers rely on contract testing services, potentially causing delays during periods of high demand. The financial barrier is particularly pronounced in emerging markets, where local laboratories often lack the resources to acquire advanced analytical platforms, resulting in reliance on international testing providers and extended turnaround times for safety assessments.

Other drivers and restraints analyzed in the detailed report include:

• Expansion of global processed-food trade
• Harmonized reference-dose rules lowering LOQs
• Complexity of multi-allergen testing

Segment Analysis

In 2025, immunoassay-based techniques are expected to dominate the market, accounting for 58.17% of the share due to their reliability, cost-effectiveness, and broad compliance with international food safety standards. PCR-based approaches are projected to grow at a CAGR of 7.38% through 2031, driven by their high specificity and ability to detect multiple allergens simultaneously. Mass spectrometry is increasingly utilized for confirmatory testing, particularly in processed foods where protein modifications can affect the accuracy of immunoassays. Spectroscopy and imaging tools are mainly used for rapid screening, while nanobiosensor platforms are advancing on-site testing through smartphone integration and AI-driven analysis.

The market is shifting toward hybrid systems that integrate multiple detection methods to address technical limitations while maintaining cost efficiency for routine testing. Advanced biosensors employing gold nanoparticles and graphene-based transducers are achieving femtomolar-level sensitivity, surpassing the performance of traditional ELISA methods and enabling the detection of trace allergens that were previously undetectable. However, regulatory approval remains a significant challenge, as compliance with ISO 16140-2 requires extensive validation studies, often delaying market entry by 2-3 years.

Complete Report Scope:

• By Technology
  • Immunoassay-Based
  • Polymerase Chain Reaction-Based
  • Mass-Spectrometry-Based
  • Spectroscopy and Imaging
  • Others
• By Application
  • Bakery and Confectionery
  • Dairy Products
  • Seafood and Meat Products
  • Beverages
  • Baby Food and Infant Formula
  • Others
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • South Africa
    • Rest of Middle East and Africa

Geography Analysis

In 2025, Europe leads the allergen testing market with a 34.47% share, driven by robust regulatory frameworks and a well-established testing infrastructure across government laboratories and private service providers. Continuous updates from the European Food Safety Authority on allergen assessment, coupled with stringent cross-contact prevention standards set by the Dutch Food and Consumer Product Safety Authority, highlight the region's strict regulatory environment. These factors sustain consistent demand for allergen testing in the region. North America operates under established FDA and USDA frameworks, with market growth primarily fueled by technological innovations rather than regulatory changes. The region benefits from advanced testing infrastructure and protocols, focusing on integrating emerging allergen detection technologies to enhance efficiency and optimization. This approach emphasizes technological progress over fundamental regulatory reform.

The Asia-Pacific region is the fastest-growing allergen testing market, with a projected CAGR of 8.98% through 2031. Growth is supported by evolving food safety regulations in China and India as they align with international standards to enhance food export capabilities. Additionally, the rising prevalence of food allergies in Japan drives demand, while South Korea and Australia serve as key testing hubs for multinational food companies operating in the region. South America, along with the Middle East and Africa, presents emerging growth opportunities due to developing regulatory systems and export-driven compliance requirements. However, market growth in these regions is limited by insufficient local analytical capacity and reliance on international testing services.

The global allergen testing market demonstrates a clear correlation between regulatory maturity and testing adoption. Regions with stronger regulatory frameworks invest in analytical capabilities to ensure food safety and enhance competitiveness in global trade. Meanwhile, emerging markets are progressively building their testing infrastructure to align with international standards, fostering long-term growth potential. Despite challenges in developing regions, increasing awareness of international food safety standards is driving gradual improvements in testing infrastructure, supporting the overall expansion of the allergen testing market.

List of Companies Covered in this Report:

• Eurofins Scientific SE
• SGS SA
• Intertek Group PLC
• Bureau Veritas SA
• Microbac Laboratories Inc.
• Thermo Fisher Scientific
• Neogen Corporation
• Mérieux NutriSciences
• Agilent Technologies
• Romer Labs
• ALS Limited
• FOSS
• Charm Sciences
• Bio-Rad Laboratories
• 3M Company
• Quest Diagnostics
• EMSL Analytical
• Danaher Corporation
• bioMérieux
• Hygiena
• PerkinElmer
• R-Biopharm AG
• Shimadzu Corporation

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support